Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Western Firms Prepare To Capitalize On Chinese Reimbursement Reform

Executive Summary

Western drug-makers are positioning themselves to capitalize on a multi-billion dollar health care reform program outlined by the Chinese government earlier this year

You may also be interested in...

Over There: Sanofi-Aventis Details Plans for Emerging Markets

Citing a "competitive advantage," Sanofi aims to double sales in new markets from €6.5 billion in 2008 to €17 billion by 2013.

Chinese Premier Wen Jiabao Allocates Healthcare Investment, But Essential Drug List Delayed Again

SHANGHAI - China's State Council issued additional healthcare reform plans July 8 to detail the goals of the country's ambitious reform plan. However, the release of the long-awaited essential drug list will be delayed to the end of this year, which was expected to be issued by June

More Investment In China’s Health Care System Unveiled During NPC;  Is It Time To Ask Who Will Benefit First And Most?

SHANGHAI - With the world economy in a downturn, the annual session of China's National People's Congress, one of the most important meetings in the country, is being held in Beijing





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts